文献速递介入外周血管泌尿生殖CTDSA

经皮射频消融行肾交感神经去神经术治疗高血压的安全性与有效性

Safety and Efficacy of Renal Sympathetic Denervation Using Percutaneous Radiofrequency Ablation, a New Hypertension Treatment.
PubMed 文献 · Acad Radiol · 2025-12-15

研究在14只比格犬中评估CT引导经皮射频消融行肾交感神经去神经术的可行性、有效性和安全性,手术全部成功,3个月时去甲肾上腺素较基线降低73%、肾上腺素降低55%(P均<.05),组织学显示可消融距肾动脉≥4 mm的交感神经,但出现1例肾出血和3只犬(14侧中3侧)输尿管狭窄致肾积水。

要点

  • CT引导经皮射频消融可消融距肾动脉≥4 mm的交感神经,弥补常规导管法不足。
  • 术后3个月去甲肾上腺素较基线降低73%、肾上腺素降低55%(P均<.05)。
  • 14只犬中1例肾出血、3只犬(14侧中3侧)输尿管狭窄致肾积水,无肾动脉狭窄和死亡。

核心结论

  • 经皮射频消融行肾交感神经去神经术能消融常规方法难以到达的距肾动脉≥4 mm区域的肾交感神经,并降低去甲肾上腺素和肾上腺素水平。

研究设计与样本

  • 动物实验,14只比格犬分为去神经组和对照组,去神经组在CT引导下行经皮射频消融双侧肾动脉周围交感神经,术前、术后3天、1周和3个月检测肾功能及去甲肾上腺素、肾上腺素、醛固酮和肾素水平,3个月后行血管造影评估肾动脉狭窄或闭塞并对肾动脉周围交感神经行组织学评估。

关键影像表现/征象

  • 组织学显示所有可观察的消融区域中距肾动脉≥4 mm的交感神经均发生去神经支配。
  • 3个月后血管造影未发现肾动脉狭窄,手术及随访期间无犬死亡。

诊断标准与关键数值

  • 术后3个月平均血去甲肾上腺素较基线降低73%(P < .05)。
  • 术后3个月平均血肾上腺素较基线降低55%(P < .05)。

局限性

  • 原文报告1例肾出血。
  • 原文报告3只犬(14侧中3侧)出现输尿管狭窄所致肾积水。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Conventional catheter-based renal sympathetic denervation (RDN) as a treatment for patients with treatment-resistant hypertension cannot ablate renal sympathetic nerves ≥4 mm from the renal artery. We developed a percutaneous radiofrequency ablation (pRFA) method to ablate remote renal sympathetic nerves. This study aimed to assess the feasibility, efficacy, and safety of RDN with pRFA.

MATERIALS AND METHODS: Fourteen Beagle dogs were divided into RDN and control groups. The RDN group underwent computed tomography (CT)-guided pRFA to ablate the sympathetic nerves around bilateral renal arteries. Renal function (creatinine) and levels of noradrenaline, adrenaline, aldosterone, and renin were measured preoperatively, 3 days, 1 week, and 3 months after the procedure. Three months later, angiography was performed to evaluate renal artery stenosis or occlusion, and sympathetic nerves around the renal artery were evaluated histologically.

RESULTS: The procedure was successful in all cases, but there was one case of renal hemorrhage, and hydronephrosis due to ureteral stricture was seen in three dogs (three of 14 sides). No renal artery stenosis occurred and no dogs died during the procedure or follow-up. Significant decreases from baseline to 3 months later were seen in mean blood levels of noradrenaline (-73%; P < .05) and adrenaline (-55%; P < .05). Histologically, all ablation regions that could be observed showed denervation in sympathetic nerves ≥4 mm from the renal artery.

CONCLUSION: RDN with pRFA was able to ablate renal sympathetic nerves in regions in which conventional methods would have been inadequate, resulting in decreased levels of noradrenaline and adrenaline.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Yonezawa H, Yamamoto A, Kageyama K, et al. Safety and Efficacy of Renal Sympathetic Denervation Using Percutaneous Radiofrequency Ablation, a New Hypertension Treatment. Acad Radiol. 2025. PMID: 41402179. doi:10.1016/j.acra.2025.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。